NCT02203851 Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02203773 Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML) Status TERMINATED Phase PHASE1
NCT02198651 A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects Status COMPLETED Phase PHASE4
NCT02196701 Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study Status COMPLETED Phase PHASE3
NCT02187861 A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL) Status COMPLETED Phase PHASE2
NCT02185014 Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115 Status COMPLETED Phase PHASE3
NCT02167945 A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection Status COMPLETED Phase PHASE3
NCT02163694 A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer Status COMPLETED Phase PHASE3
NCT02162472 Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis Status COMPLETED Phase N/A
NCT02158507 Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer Status COMPLETED Phase NA
NCT02148718 Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease Status COMPLETED Phase PHASE4
NCT02143713 Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain Status COMPLETED Phase PHASE3
NCT02142959 RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Status COMPLETED Phase PHASE2
NCT02141997 A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE2
NCT02141282 A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy Status COMPLETED Phase PHASE2
NCT02130362 A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02128113 RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Status COMPLETED Phase PHASE2
NCT02106546 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3